6 курс / Кардиология / Омега_3_полиненасыщенные_жирные_кислоты_в_современной_кардиологической

Fritsche K. Fatty acids as modulators of the immune response // Annu. Rev. Nutr. – 2006. – V.26. – P. 45–73.

Galan P., Kesse–Guyot E., Czernichow S. et al. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial // BMJ. – 2010. – V.341. – P. c6273.

Geelen A, Brouwer IA, Schouten EG et al. Effects of n–3 fatty acids from fish on premature ventricular complexes and heart rate in humans // Am. J. Clin. Nutr. – 2005. – V.81, N.2. – P. 416–420.

Ghio S., Scelsi L., Latini R. et al. Effects of n–3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI–HF trial // Eur. J. Heart. Fail. – 2010. – V.12, N.12. – P. 1345–1353.

Gillum R.F., Mussolino M.E., Madans J.H. The relationship between fish consumption and stroke incidence. The NHANES I Epidemiologic Follow–up Study (National Health and Nutrition Examination Survey) // Arch. Intern. Med.

– 1996. – V.156, N.5. – P. 537–542.

GISSI–HF Investigators. Effect of n–3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI–HF trial): a randomised, double–blind, placebo–controlled trial // Lancet. – 2008a. – V.372, N.9645. – P. 1223–2230.

GISSI–HF investigators. Effect of rosuvastatin in patients with chronic heart failure (the GISSI–HF trial): a randomized, double–blind, placebo– controlled trial // Lancet. – 2008b. – V.372, N.9645. – P.1231–1239.

GISSI–Prevenzione Investigators. Dietary supplementation with n–3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI–Prevenzione trial Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico // Lancet. – 1999. – V.354, N.9177. – P. 447–455.

Grabowski M. Ethylester omega–3 fatty acids in heart failure––results of GISSI–HF studies // Kardiol. Pol. – 2008. – V.66, N.11. – P. 1243–1244.

Greenland P., Bonow R.O., Brundage B.H. et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) // J. Am. Coll. Cardiol. – 2007. – V.49, N.3. – P. 378–402.

Guallar E., Hennekens C.H., Sacks F.M. et al. A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians // J. Am. Coll. Cardiol. – 1995. – V.25, N.2. – P. 387–394.

Halcox J.P. Letter by Halcox regarding article, "OMEGA, a randomized, place- bo–controlled trial to test the effect of highly purified omega–3 fatty acids on top of modern guideline–adjusted therapy after myocardial infarction" // Circulation. – 2011. – V.124, N.1. – P. e21.

~ 141 ~

Hallgren C.G., Hallmans G., Jansson J.H. et al. Markers of high fish intake are associated with decreased risk of a first myocardial infarction // Br. J. Nutr. – 2001. – V.86, N.3. – P. 397–404.

Hamazaki T. The first randomized clinical trial of 2 y to prevent reinfarction with fish oil // Eur. J. Clin. Nutr. – 2004. – V.58, N.11. – P.1557.

Harris W.S. Extending the cardiovascular benefits of omega–3 fatty acids // Curr. Atheroscler. Rep. – 2005. – V.7, N.5. – P. 375–380.

Harris W.S., Gonzales M., Laney N. et al. Effects of omega– 3 fatty acids on heart rate in cardiac transplant recipients // Am. J. Cardiol. – 2006. – V.98, N.10. –P. 1393–1395.

Harris W.S., Sands S.A., Windor S.L. et al. Omega– 3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation // Circulation. – 2004. – V.110, N.12. – P. 1645– 1649.

Harris W.S., von Schacky C. Omega–3 Fatty Acids, Acute Coronary Syndrome, and Sudden Death // Curr. Cardiovasc. Risk. Reporets. – 2008. – V.2, N.11. –P. 161–166.

Harris W.S., von Schacky C. Omega–3 Fatty Acids, Acute Coronary Syndrome, and Sudden Death // Curr. Cardiovasc. Risk Reporets. – 2008. – V.2, N.2. – P. 161– 166.

Harris W.S., von Schacky C. The Omega–3 Index: a new risk factor for death from coronary heart disease? // Prev. Med. – 2004. – V.39, N.1. – P. 212– 220. Harrison N., Abhyankar B. The mechanism of action of omega–3 fatty acids in secondary prevention post–myocardial infarction // Curr. Med. Res. Opin. – 2005. – V.21, N.1. – P. 95–100.

He K., Rimm E.B., Merchant A. et al. Fish consumption and risk of stroke in men // JAMA. – 2002. – V.288, N.24. – P. 3130–3136.

He K., Song Y., Daviglus M.L. et al. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta–analysis of cohort studies // Circulation. – 2004a. – V.109, N.22. – P. 2705–2711.

He K., Song Y., Daviglus M.L. et al. Fish consumption and incidence of stroke: a meta–analysis of cohort studies // Stroke. – 2004b. – V.35, N.7. – P. 1538–1542.

Heemskerk J.W., Vossen R.C., van Dam–Mieras M.C. Polyunsaturated fatty acids and function of platelets and endothelial cells // Curr. Opin. Lipidol. – 1996. – V.7, N.1. – P. 24 – 29.

Heidarsdottir R., Arnar D.O., Skuladottir G.V. et al. Does treatment with n– 3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery? // Europace. – 2010. – V.12, N.3. – P. 356–363.

Heidt M.C., Vician M., Stracke S.K. et al. Beneficial effects of intravenously administered N– 3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study // Thorac. Cardiovasc. Surg. – 2009. – V.57, N.5. – P. 276–280.

~ 142 ~

Hohnloser S.H., Klingenheben T., Zabel M. et al. T–wave alternans during exercise and atrial pacing in humans // J. Cardiovasc. Electrophysiology. – 1997.

– V.8, N.9. – P. 987–993.

Holman R.T. Nutritional and metabolic interrelationships between fatty acids // Fed. Proc. – 1964. – V.23. – P. 1062–1067.

Holman R.T. The slow discovery of the importance of omega 3 essential fatty acids in human health // J. Nutr. – 1998. – V.128, Suppl. 2. – P. 427S–433S. Holub D.J., Holub B.J. Omega–3 fatty acids from fish oils and cardiovascular disease // Mol. Cell. Biochem. – 2004. – V.263, N.1–2. – P. 217–

Hooper L., Thompson R.I., Harrison R.A. et al. Risks and benefits of Omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review // BMJ. – 2006. – V.332, N.7544. – P. 752 – 760.

Hornstra G. Influence of dietary fat type on arterial thrombosis tendency // J. Nutr. Health & Ageing. – 2001. – V.5, N3. – Р. 160–166.

Hu F.B. The Mediterranean diet and mortality–olive oil and beyond // N. Engl. J. Med. – 2003. – V.348, N.26. – P. 2595–2596.

Hu F.B., Bronner L., Willett W.C. et al. Fish and omega–3 fatty acid intake and risk of coronary heart disease in women // JAMA. – 2002. – V.287, N.14. – P. 1815–1821.

Hunter D.J., Kazda I., Chockalingam A., Fodor J.G. Fish consumption and cardiovascular mortality in Canada: an inter–regional comparison // Am. J. Prev. Med. – 1988. – V.4, N.1. – P.5–9.

Iso H., Kobayashi M., Ishihara J. et al. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center– Based (JPHC) Study Cohort I // Circulation. – 2006. – V.113, N.2. – P. 195– 202.

Iso H., Rexrode K.M., Stampfer M.J. et al. Intake of fish and omega–3 fatty acids and risk of stroke in women // JAMA. – 2001. – V.285, N.3. – P.304–312. Jha P, Flather M., Lonn E. et al. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data // Ann. Intern. Med. – 1995. – V.123, N.11. – P. 860–872.

Kang J.X., Leaf A. Antiarrhythmic effects of polyunsaturated fatty acids // Recent studies // Circulation. – 1996. – V.94, N.7. – P. 1774–1780.

Kang J.X., Leaf A. Evidence that free polyunsaturated fatty acids modify Na+ channels by directly binding of the channel proteins // Proc. Natl. Acad. Sci. USA. – 1996. – V.93, N.8. – P. 3542–3546.

Keli S.O., Feskens E.J., Kromhout D. Fish consumption and risk of stroke. The Zutphen Study // Stroke. – 1994. – V.25, N.2. – P. 328–332.

Keys A. Mediterranean diet and public health: personal reflections // American Journal of Clinical Nutrition. – 1995. – V.61, Suppl.6. – P. 1321S–1323S.

Keys A. Seven countries: a multivariate analysis of death and coronary heart disease. – London: Harvard University Press, 1980. – 381 p.

~ 143 ~

Keys A., Menotti A., Aravanis C. et al. The seven countries study: 2,289 deaths in 15 years // Prev. Med. – 1984. – V.13, N.2. – P. 141–154.

Khawaja О., Gaziano J.М., Djoussé L. A Meta– Analysis of Omega– 3 Fatty Acids and Incidence of Atrial Fibrillation // J. Am. Coll. Nutr. February. – 2012.

– V.31, N.1. – P. 4–13.

Khoo K.L., Tan H., Liew Y.M. et al. Lipids and coronary heart disease in Asia // Atherosclerosis. – 2003. – V.169, N.1. – P. 1–10.

Knoops K.T., de Groot L.C., Kromhout D. et al. Mediterranean diet, lifestyle factors, and 10–year mortality in elderly European men and women: the HALE project // JAMA. – 2004. – V.292, N.12. – P. 1433–1439.

Kostos J.B., Byington R., Friedman L.M. et al. Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction // J. Amer. Coll. Cardiology. – 1987. – V.10, N.2. – P. 231–242.

Kowey P.R., Reiffel J.A., Ellenbogen K.A. et al. Efficacy and safety of prescription omega– 3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial // J. Am. Med. Assoc. – 2010. – V.304, N. 21. – P. 2363–2372.

Kremer J.M. Effects of modulation of inflammatory disease receiving dietary supplementation of n–3 and n–6 fatty acids // Lipids. – 1996. – Vol.31, Suppl. – S. 243 – 247.

Kris–Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega–3 fatty acids, and cardiovascular disease // Circulation. – 2002. – V.106, N.21. – P. 2747–2757.

Kris–Etherton P.M., Harris W.S., Appel L.J. Omega–3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association // Arterioscler. Thromb. Vasc. Biol. – 2003. – V.23, N.2. – P. 151–152.

Kris–Etherton P.M., Taylor D.S., Yu–Poth S. et al. Polyunsaturated fatty acids in the food chain in the United States // Am. J. Clin. Nutr. – 2000. – V.71, Suppl.1. – P. 179S–188S.

Kris–Etherton P.M., Harris W.S. Adverse effect of fish oils in patients with angina? // Curr. Atheroscler. Rep. – 2004. – V.6, N.6. – P. 413–414.

Kromann N., Green A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic disease 1950–1974 // Acta Med. Scand. 1980. – V.208, N5. – P. 401–406.

Kromhout D., Bosschieter E.B., de Lezenne Coulander C. The inverse relation between fish consumption and 20–year mortality from coronary heart disease // N. Engl. J. Med. – 1985. – V.312, N.19. – P. 1205–1209.

Kromhout D., Giltay E.J., Geleijnse J.M. for the Alpha Omega Trial Group. n–3 fatty acids and cardiovascular events after myocardial infarction // The New England journal of medicine. – 2010. – V.363, N.21. – P. 2015–2026.

Kromhout D., Keys A., Aravanis C. et al. Food consumption patterns in the 1960s in seven countries // American Journal of Clinical Nutrition. – 1989. – V.49, N.5. – P. 889–894.

~ 144 ~

Lampe F.C., Whincup P.H., Wannamethee S.G. et al. The natural history of prevalent ischaemic heart disease in middle–aged men // Eur. Heart J. – 2000. – V.21, N.13. – P. 1052–1062.

Lapidus L., Andersson H., Bengtsson C., Bosaeus I. Dietary habits in relation to incidence of cardiovascular disease and death in women: a 12–year follow–up of participants in the population study of women in Gothenburg, Sweden // Am. J. Clin. Nutr. – 1986. – V.44, N.4. – P. 444–451.

Lavie C.J., Milani R.V., Mehra M.R., Ventura H.O. Omega–3 Polyunsaturated Fatty Acids and Cardiovascular Diseases // J. Am. Coll. Cardiol. – 2009. – V.54, N.7. – P. 585–594.

Leaf A. Dietary prevention of coronary heart disease: the Lyon Diet Heart Study // Circulation. – 1999. – V.99, N.6. – P. 733–735.

Leaf A., Albert C.M., Josephson M. et al. Prevention of fatal arrhythmias in high– risk subjects by fish oil n– 3 fatty acid intake // Circulation. – 2005. – V.112, N.18. – P. 2762–2768.

Leaf A., Kang J.X., Xiao Y.F., Billman G.E. Clinical prevention of sudden cardiac death by n–3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n–3 fish oils // Circulation. 2003. – V. 107, N.21. – P. 2646.

Lee J.H., O'Keefe J.H., Lavie C.J. et al. Omega–3 fatty acids for cardioprotection // Mayo. Clin. Proc. – 2008. – V.83, N.3. – P. 324–332.

Lemaitre R.N., King I.B., Mozaffarian D. et al. N–3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study // Am. J. Clin. Nutr. – 2003. – V.77, N.2. – P. 319–325.

León Н., Shibata M., Sivakumaran S. et al. Effect of fish oil on arrhythmias and mortality: systematic review // BMJ. – 2008. – V.337. – P. a2931.

Lichtenstein A.H., Appel L.J., Brands M. et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee // Circulation. – 2006. – V.114, N.1. – P. 82–96.

Liu T., Korantzopoulos P., Shehata M. et al. Prevention of atrial fibrillation with omega– 3 fatty acids: a meta– analysis of randomised clinical trials // Heart. – 2011. – V.97, N.13. – P. 1034–1040.

London В., Albert С., Anderson М.Е. et al. Omega–3 Fatty Acids and Cardiac Arrhythmias: Prior Studies and Recommendations for Future Research: A Report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega–3 Fatty Acids and Their Role in Cardiac Arrhythmogenesis Workshop // Circulation. – 2007. – V.116, N.10. – P. e320–e335.

Lorenz M.W., Markus H.S., Bots M.L. et al. Prediction of clinical cardiovascular events with carotid intima–media thickness: a systematic review and meta– analysis // Circulation. – 2007. – V.115, N.4. – P. 459–467.

de Logeril M., Salen P., Martin J.L. et al. Mediterranean alpha–linolenic ac- id–rich diet in secondary prevention of coronary artery disease // Circulation. – 1999. – V. 99, N.6. – P. 779–785.

~ 145 ~

de Lorgeril M., Renaud S., Mamelle N. et al. Mediterranean alpha–linolenic acid–rich Mediterranean Diet and Coronary Heart Disease diet in secondary prevention of coronary heart disease // Lancet. – 1994. – V.343, N.8911. – P. 1454–1459.

de Lorgeril M., Salen P. Dietary prevention of coronary heart disease: focus on omega–6/omega–3 essential fatty acid balance // World Rev. Nutr. Diet. – 2003.

– V.92. – P. 57–73.

de Lorgeril M., Salen P., Monjaud I., Delaye J. The diet heart hypothesis in secondary prevention of coronary heart disease // Eur. Heart. J. – 1997. – V. 18, N.1. – P. 14–18.

Lown B., Wolf M. Approaches to sudden death from coronary heart disease // Circulation. – 1971. – V.44, N.1. – P. 130–142.

Macchia A., Levantesi G., Franzosi M.G. et al. Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n–3 polyunsaturated fatty acids // Eur. J. Heart. Fail. – 2005. – V.7, N.5. – P. 904–909.

Macchia A., Monte S., Pellegrini F. et al. Omega– 3 fatty acid supplementation reduces one–year risk of atrial fibrillation in patients hospitalized with myocardial infarction // Eur. J. Clin. Pharmacol. – 2008. – V.64, N.6. – P. 627–634.

Madsen T., Christensen J.H., Thøgersen A.M. et al. Intravenous infusion of n– 3 polyunsaturated fatty acids and inducibility of ventricular tachycardia in patients with implantable cardioverter defibrillator // Europace. – 2010. – V.12, N.7. – P. 941–946.

Madsen T., Skou H.A., Hansen V.E. et al. C–reactive protein, dietary n–3 fatty acids, and the extent of coronary artery disease // American Journal of Cardiology. – 2001. – V. 88, N.15. – P. 1139–42

Maggioni A.P., Fabbri G., Lucci D. et al. Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI–HF trial // Eur. Heart. J. – 2009. – V.30, N.19. – P. 2327–2336.

Management of acute myocardial infarction in patients presenting with persistent ST–segment elevation. ESC Guidelines // Engl. Heart. J. – 2008. – V.29, N.23. – P. 2909–2945.

Mantzioris E., Cleland L.G., Gibson R.A. et al. Biochemical effect of a diet containing foods enriched with n–3 fatty acids // Am. J. Clin. Nutr. – 1997. – V.72, N.1. – P. 42–48.

Marchioli R., Avanzini F., Barzi F. Assessment of absolute risk of death after myocardial infarction by use of multiple–risk–factor assessment equations: GISSI–Prevenzione mortality risk chart // Eur. Heart. J. – 2001. – V.22, N.22. – P. 2085–2103.

Marchioli R., Barzi F., Bomba E. et al. Early protection against sudden death by n–3 polyunsaturated fatty acids after myocardial infarction: time–course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza

~ 146 ~

nell’Infarto Miocardico (GISSI)–Prevenzione // Circulation. – 2002. – V.105, N.16. – P. 1897–1903.

Mariscalco G., Sarzi Braga S., Banach M. et al. Preoperative n– 3 polyunsaturated fatty acids are associated with a decrease in the incidence of early atrial fibrillation following cardiac surgery // Angiology. – 2010. – V.61, N.7. – P. 643– 650.

Matsuzaki M., Yokoyama M., Saito Y. et al. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin–treated patients with coronary artery disease // Circ. J. – 2009. – V.73, N.7. – P.1283–1290.

Metcalf R.G., Sanders P., James M.J. et al. Effect of dietary n– 3 polyunsaturated fatty acids on the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy // Am. J. Cardiol. – 2008. – V.101, N.6. – P. 758–761.

Montori V.M., Farmer A., Wollan P.C., Dinneen S.F. Fish oil supplementation in type 2 diabetes: a quantitative systematic review // Diabetes Care.– 2000.– V. 23, N.9.– Р. 1407–1415.

Moore M.J., Glover B.M., McCann C.J. et al. Demographic and temporal trends in out of hospital sudden cardiac death in Belfast // Heart. – 2006. – V.92, N.3. – P. 311–315.

Mori T.A., Beilin L.J., Burke V. et al. Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease // Arterioscler. Thromb. Vasc. Biol. – 1997. – V.17, N.2. – P. 279– 86.

Morris M.C., Manson J.E., Rosner B. et al. Fish consumption and cardiovascular disease in the physicians' healthy study: a prospective study // Am. J. Epidemiol. – 1995. – V.142, N2. – P. 166–175.

Mozaffarian D., Bryson C.L., Lemaitre R.N. et al. Fish intake and risk of incident heart failure // J. Am. Coll. Cardiol. – 2005a. – V.45, N.12. – P. 2015– 2021.

Mozaffarian D., Lemaitre R.N., Kuller L.H. et al. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study // Circulation. – 2003 – V.107, N.10. – P. 1372–1377.

Mozaffarian D., Longstreth W.T., Lemaitre R.N. et al. Fish consumption and stroke risk in elderly individuals: the cardiovascular health study // Arch. Intern. Med. – 2005b. – V.165, N.2. – P. 200–206.

Mozaffarian D., Marchioli R., Gardner T. et al. The ω– 3 fatty acids for prevention of post– operative atrial fibrillation trial – rationale and design // Am. Heart J. – 2011. – V.162, N.1. – P. 56–63.

Mozaffarian D., Psaty B.M., Rimm E.B. et al. Fish intake and risk of incident atrial fibrillation // Circulation. – 2004. – V.10, N.4. – P. 368–373. Mozaffarian D., Rimm E. Fish Intake, Contaminants, and Human Health Evaluating the Risks and the Benefits // JAMA. – 2006. – V.296, N.15. – P. 1885– 1899.

~ 147 ~

Mozaffarian D„ Prineas R.J., Stein P.K. et al. Dietary fish and n– 3 fatty acid intake and cardiac electrocardiographic parameters in humans // J. Am. Coll. Cardiol. – 2006. – V.48, N.3. – P. 478–484.

Myerburg R.J., Kessler K.M., Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment // Ann. Intern. Med. – 1993. – V.119, N.12. – P. 1187–1197.

Myint P.K., Welch A.A., Bingham S.A. et al. Dietary fish intake and plasma phospholipid n–3 polyunsaturated fatty acid concentrations in men and women in the European Prospective Investigation into Cancer–Norfolk United Kingdom cohort // Am. J. Clin. Nutr. – 2006. – V.84, N.6. – P. 1330–1339.

Myint P.K., Welch A.A., Bingham S.A. et al. Habitual fish consumption and risk of incident stroke: the European Prospective Investigation into Cancer (EPIC)–Norfolk prospective population study// Public Health Nutr. – 2006. – V.9, N.7. – P. 882–888.

Nahab F., Le A., Judd S. et al. Racial and geographic differences in fish consumption: the REGARDS study // Neurology. – 2011. – V.76, N.2. – P. 154– 158.

Nakamura Y., Ueshima H., Okamura T. et al. Association between fish consumption and allcause and cause–specific mortality in Japan: NIPPON DATA80, 1980–99 // Am. J. Med. – 2005. – V.118, N.3. – P. 239–45.

Ness A.R., Ashfield–Watt P. A.L., Whiting J.M. et al. The long–term effect of dietary advice on the diet of men whith angina: the diet and angina randomized trial // J. Hum. Nutr. Diet. – 2004. – V.17, N.2. – P. 117–119.

Ness A.R., Hughes J., Elwood P.C. et al. The long–term effect of dietary advice in men with coronary disease: follow–up of the Diet and Reinfarction trial // Eur. J. Clin. Nutr. – 2002. – V.56, N.6. – P. 512–528.

Nilsen D.W., Albrektsen G., Landmark K. et al. Effects of a high–dose concentrate of n–3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol // Am. J. Clin. Nutr. – 2001. – V.74, N.1. – P. 50–56.

Nilsen D.W., Harris W.S. N–3 Fatty acids and cardiovascular disease // Am. J. Clin. Nutr. – 2004. – V.79, N.1. – P. 166

Niu K., Hozawa A., Kuriyama S. et al. Dietary long–chain n–3 fatty acids of marine origin and serum C–reactive protein concentrations are associated in a population with a diet rich in marine products // Am. J. Clin. Nutr. – 2006. – V.84, N.1. – P. 223–9.

Njelekela M., Ikeda K., Mtabaji J., Yamori Y. Dietary habits, plasma polyunsaturated fatty acids and selected coronary disease risk factors in Tanzania // East Afr. Med. J. – 2005. – V.82, N.11. – P. 572–578.

Nodari S., Metra M., Milesi G. et al. The role of n– 3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy // Cardiovasc. Drugs Ther. – 2009. – V.23, N.1. – P. 5–15.

~ 148 ~

Nodari S., Triggiani M., Campia U. et al. N– 3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study // Circulation. – 2011. – V.124, N.10. – P. 1100– 1106.

Norum K.R. Dietary fat and blood lipids // Nutr. Rev. – 1992. – V.50, N.4. – P. 30–37.

Okayama A., Ueshima H., Marmot M. et al. Generational and regional differences in trends of mortality from ischemic heart disease in Japan from 1969 to 1992 // Am. J. Epidemiol. – 2001. – V.153, N.12. – P. 1191–1198.

O'Keefe J.H. Jr, Abuissa H., Sastre A. et al. Effects of omega– 3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions // Am. J. Cardiol. – 2006. – V.97, N.8. – P.1127–1130.

Okuda N., Ueshima H., Okayama A. et al. Relation of long chain ω–3 polyunsaturated fatty acid intake to serum high density lipoprotein cholesterol among Japanese men in Japan and Japanese–American men in Hawaii: the INTERLIPID study // Atherosclerosis. – 2005. – V.178, N2. – P. 371–379.

Oomen C.M., Feskens E.J., Rasanen L. et al. Fish consumption and coronary heart disease mortality in Finland, Italy, and the Netherlands // Am. J. Epidemiol. – 2000. – V.151, N.10. – P. 999–1006.

Orencia A.J., Daviglus M.L., Dyer A.R. et al. Fish consumption and stroke in men. 30–year findings of the Chicago Western Electric Study //Stroke. – 1996. – V.27, N.2. – P. 204–209.

Osler M., Andreasen A.H., Hoidrup S. No inverse association between fish consumption and risk of death from all–causes, and incidence of coronary heart disease in middle–aged, Danish adults // J. Clin. Epidemiol. – 2003. – V.56, N.3.

– P. 274–279.

Papageorgiou N., Tousoulis D., Stefanadis Ch. Letter by Papageorgiou et al. Regarding Article, “OMEGA, A Randomized, Placebo–Controlled Trial to Test the Effect of Highly Purified Omega–3 Fatty Acids on Top of Modern Guide- line–Adjusted Therapy After Myocardial Infarction” // Circulation. – 2011. – V.124, N.1. – P. e22.

Pase M.P., Grima N.A., Sarris J. Do long–chain n–3 fatty acids reduce arterial stiffness? A meta–analysis of randomised controlled trials // Br. J. Nutr. – 2011.

– V.106, N.7. – P. 974–980

Patel D., Shaheen M., Venkatraman P. et al. Omega– 3 polyunsaturated fatty acid supplementation reduced atrial fibrillation recurrence after pulmonary vein antrum isolation // Indian Pacing Electrophysiol. J. – 2010. – V.9, N.6. – P. 292– 298.

Pratt C.M., Reiffel J.A., Ellenbogen K.A. et al. Efficacy and safety of prescription omega– 3– acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: a prospective study // Am. Heart J. – 2009. – V.158, N.2. – P. 163–169.

~ 149 ~

Psota T.L., Gebauer S.K., Kris–Etherton P. Dietary omega–3 fatty acid intake and cardiovascular risk // Am. J. Cardiol. – 2006. – V.98, N.4A. – P. 3i– 18i.

Raitt M.H., Connor W.E., Morris C. et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial // JAMA. – 2005. – V.293, N.23.

– P. 2884–2891.

Rauch B., Schiele R., Schneider S. et al. OMEGA, a randomized, placebo– controlled trial to test the effect of highly purified omega–3 fatty acids on top of modern guideline–adjusted therapy after myocardial infarction // Circulation. – 2010. – V.122, N.21. – P. 2152–2159.

Rauch В., Senges J. The effects of supplementation with omega– 3 polyunsaturated Fatty acids on cardiac rhythm: anti– arrhythmic, pro– arrhythmic, both or neither? It depends…. // Front Physiol. – 2012. – V.3. – P. 57.

Reaven G.M. Diet and Syndrome X // Cur. Atheroscler. Rep. – 2000. – V.2, N.6. – P. 503 – 507.

Reiner Z., Catapano A.L., De Backer G. et al. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) // Eur. Heart J. – 2011. – V.32, N.14. – p. 1769–1818.

Renaud S., de Lorgeril M., Delaye J. et al. Cretan Mediterranean diet for prevention of coronary heart disease // American Journal of Clinical Nutrition. – 1995. – V.61, Suppl. 6. – P. 1360S–1367S.

Rillaerts E.G., Engelmann G.I., Van Camp K.M. De Leeuw I. Effect of omega–3 fatty acids in diet of type I diabetic subjects on lipid values and hemorheological parameters // Diabetes. – 1989. – V.38, N.11. – P. 1412–1416.

Robertson T.L., Kato H., Rhoads G.G. et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Incidence of myocardial infarction and death from coronary heart disease // Am. J. Cardiol. – 1977. – V.39, N.2. – P. 239–243.

Rodriguez B.L., Sharp D.S., Abbott R.D. et al. Fish intake may limit the increase in risk of coronary heart disease morbidity and mortality among heavy smokers. The Honolulu Heart Program // Circulation. – 1996. – V.94, N5. P. – 952–956.

Rupp H., Rupp T.P., Alter P. et al. N–3 polyunsaturated fatty acids and statins in heart failure // Lancet. – 2009. - V.373, N.9661. – P. 378–379.

Saito Y., Yokoyama M., Origasa H. et al. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub–analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS) // Atherosclerosis. – 2008. – V.200, N.1. – P.135–140.

Sanders T.A. Polyunsaturated fatty acids in the food chain in Europe // Am. J. Clin. Nutr. – 2000. – V.71, Suppl.1. – P. 176S–178S.

~ 150 ~